Safety and Efficacy of Universal Postoperative Decolonization for Kidney Transplant Recipients

Exp Clin Transplant. 2020 Apr;18(2):153-156. doi: 10.6002/ect.2018.0341. Epub 2019 Jul 2.

Abstract

Objectives: Infection is a common cause of morbidity and mortality after kidney transplant. Based on the well-documented successes of reducing infections with decolonization of patients in intensive care units, we began a universal immediate posttransplant decolonization program for all kidney transplant recipients. Herein, we report safety and efficacy of this decolonization program.

Materials and methods: We compared a consecutive cohort of kidney transplant recipients who underwent universal decolonization (intervention group) with a cohort of transplant patients from an era immediately prior to this practice (control group). Universal decolonization included daily chlorhexidine body wash and nasal mupirocin ointment.

Results: Seventy-eight patients who underwent universal decolonization were compared with 43 patients in the control group. Ten microbiologically proven infections (8.3%) occurred in the 30 days after discharge: 7 (9%) in the intervention group and 3 (7%) in the control group. Forty-five transplant recipients (37.2%) were readmitted in the 30 days after discharge: 31 (39.7%) in the intervention group and 14 (32.6%) in the control group. No patients in the intervention group had adverse drug events from mupirocin and chlorhexidine use.

Conclusions: A universal decolonization protocol was successfully implemented and was well tolerated by all patients. Despite successful implementation, we did not observe any significant differences in infection rates between treated patients and historical controls.

MeSH terms

  • Administration, Intranasal
  • Adult
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / adverse effects
  • Anti-Infective Agents, Local / adverse effects
  • Anti-Infective Agents, Local / therapeutic use*
  • Antibiotic Prophylaxis* / adverse effects
  • Bacterial Infections / diagnosis
  • Bacterial Infections / microbiology
  • Bacterial Infections / prevention & control*
  • Bacterial Infections / transmission
  • Chlorhexidine / adverse effects
  • Chlorhexidine / therapeutic use*
  • Female
  • Humans
  • Infection Control*
  • Kidney Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Mupirocin / administration & dosage*
  • Mupirocin / adverse effects
  • Ointments
  • Program Evaluation
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents, Local
  • Ointments
  • Mupirocin
  • Chlorhexidine